Fremont, CA, US · 5 510(k) clearances
| Code | Device name | Class | Specialty | Clearances | Most recent |
|---|---|---|---|---|---|
| DJG | Enzyme Immunoassay, Opiates | Class II | Clinical Toxicology | 2 | 2023-11-09 |
| ORI | Levetiracetam Assay | Class II | Clinical Toxicology | 1 | 2024-02-27 |
| LAO | Enzyme Immunoassay, Methotrexate | Unclassified | Unknown | 1 | 2023-12-20 |
| NWM | Immunoassay, Anti-Seizure Drug | Class II | Clinical Toxicology | 1 | 2021-08-05 |
| Date | K-number | Device | Code | Class | Specialty |
|---|---|---|---|---|---|
| 2024-02-27 | K232522 | ARK Levetiracetam II Assay | ORI | Class II | Clinical Toxicology |
| 2023-12-20 | K232017 | ARK Methotrexate II Assay | LAO | Unclassified | Unknown |
| 2023-11-09 | K231752 | ARK Hydrocodone Assay | DJG | Class II | Clinical Toxicology |
| 2021-08-05 | K201089 | ARK Lacosamide Assay | NWM | Class II | Clinical Toxicology |
| 2020-02-26 | K200197 | ARK Fentanyl II Assay | DJG | Class II | Clinical Toxicology |